Realfiction (REALFI) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
31 Mar, 2026Executive summary
Revenue declined sharply in 2025 as focus shifted from legacy displays to commercializing Directional Pixel Technology (DPT).
A world-first multi-user 3D display demonstrator was completed, enabling three users to view different content simultaneously without glasses.
Strategic review initiated to explore partnerships, joint ventures, or potential sale to accelerate DPT commercialization.
Positive industry feedback on DPT, with ongoing collaborations in Taiwan and China.
Financial highlights
Q4-2025 revenue: TSEK 1,652 (down 64% YoY); full-year 2025 revenue: TSEK 4,264 (down 77% YoY).
Q4-2025 gross profit: TSEK 758 (margin 45.9%); full-year gross profit: TSEK 2,303 (margin 54.0%).
Result after financial items: Q4-2025 TSEK -6,596; full-year TSEK -30,112.
Cash flow from operating activities: Q4-2025 TSEK -710; full-year TSEK -19,711.
Equity at year-end: TSEK 48,466.
Outlook and guidance
Current cash resources expected to last until late summer 2026, factoring in early loan repayments.
Strategic review aims to secure partnerships or funding to support commercialization and address liquidity needs.
Ongoing development of larger DPT demonstrators (7-inch and 15-inch) to expand commercial applications.
Latest events from Realfiction
- Sharp revenue drop in Q3 as DPT sales paused; capital raised to support DPT commercialization.REALFI
Q3 202527 Nov 2025 - SEK 50 million rights issue supports commercialization of advanced glasses-free 3D display tech.REALFI
Status Update23 Nov 2025 - DPT commercialization advances with improved margins and new funding, despite lower revenue.REALFI
Q2 202528 Jul 2025 - Q3-2024 saw record DPT-driven revenue growth and strong gross margins, with liquidity secured.REALFI
Q3 202413 Jun 2025 - Q2-2024 saw strong revenue growth and DPT licensing talks nearing a breakthrough.REALFI
Q2 202413 Jun 2025 - DPT commercialization accelerates with new funding and industry milestones despite lower revenue.REALFI
Q1 20256 Jun 2025 - Revenue surged and DPT commercialization advanced with a pivotal license agreement.REALFI
Q4 20245 Jun 2025